Soru

Zorluk: ZorNeonatal Disorders

A term male neonate (gestational age: 39 weeks, birth weight: 3200 g) is born at home to a 28-year-old multigravida mother who received no prenatal care. APGAR scores were 7 and 8 at 1 and 5 minutes, respectively. At 48 hours of life, the infant is brought to the emergency department due to extreme jaundice, profound lethargy, and failure to feed. Vital signs are: Temperature 36.8°C, Heart rate 110/min, Respiratory rate 35/min, and SpO2 98% on room air.

Initial laboratory results are as follows:

Laboratory ParameterValueReference Range
Hemoglobin10.2 g/dL14.5 - 22.5 g/dL
Reticulocyte count12%3% - 7%
Total serum bilirubin32.5 mg/dL1.0 - 12.0 mg/dL
Direct (conjugated) bilirubin0.8 mg/dL0.1 - 0.5 mg/dL
Direct Coombs testPositive (IgG)Negative

The infant is at immediate risk for severe bilirubin-induced neurologic dysfunction. Arrange the following clinical manifestations and pathophysiological events in the correct chronological sequence, representing the classic progression of this condition from the ongoing acute insult to the permanent neurologic sequelae of kernicterus.

  1. 1Unconjugated bilirubin exceeds albumin-binding capacity and freely crosses the blood-brain barrier
  2. 2Onset of central nervous system depression, manifesting as lethargy, mild hypotonia, and poor suck
  3. 3Transition to extensor muscle hypertonia, presenting with irritability, retrocollis, and opisthotonos
  4. 4Progression to advanced acute encephalopathy with shrill cry, apneic episodes, seizures, and coma
  5. 5Permanent manifestation of chronic bilirubin encephalopathy, including choreoathetoid cerebral palsy and sensorineural hearing loss

Cevap

The correct chronological sequence is: Unconjugated bilirubin crosses the blood-brain barrier → Onset of lethargy and hypotonia (Early ABE) → Transition to hypertonia and opisthotonos (Intermediate ABE) → Progression to seizures and coma (Advanced ABE) → Permanent manifestation of choreoathetoid cerebral palsy (Chronic Kernicterus).
Bilirubin-induced neurologic dysfunction follows a highly predictable chronological progression. It is triggered when massive hemolysis, such as from Rh-alloimmunization, produces unconjugated bilirubin levels that exceed serum albumin-binding capacity. This free, lipid-soluble bilirubin freely crosses the blood-brain barrier and deposits in the basal ganglia, hippocampus, and brainstem nuclei.

The clinical syndrome begins with the early phase of acute bilirubin encephalopathy (ABE), which is characterized by hypotonia, lethargy, and a poor suck. If untreated, this progresses within days to the intermediate phase of ABE, where hypotonia paradoxically transitions into severe extensor hypertonia, clinically presenting as retrocollis (arching of the neck) and opisthotonos (arching of the back). Further toxicity leads to the advanced phase of ABE, marked by a shrill cry, apnea, clinical seizures, and profound coma. Infants who survive this acute neurotoxic insult will permanently develop chronic bilirubin encephalopathy (kernicterus) during their first year of life. Kernicterus is classically defined by the triad of choreoathetoid cerebral palsy, severe sensorineural hearing loss, and upward gaze palsy.

Adım Adım Çözüm

1
Identify the initial pathophysiologic insult.
Unconjugated bilirubin exceeds albumin-binding capacity and crosses the blood-brain barrier.
Before any clinical neurologic signs appear, the extreme hyperbilirubinemia (32.5 mg/dL) must overwhelm binding sites, allowing lipid-soluble bilirubin to deposit in the brain.
2
Identify the earliest clinical manifestations (Early Acute Bilirubin Encephalopathy).
Onset of central nervous system depression (lethargy, mild hypotonia, poor suck).
The initial clinical response to bilirubin neurotoxicity is generalized CNS depression, usually seen in the first 1 to 2 days of toxicity.
3
Identify the intermediate phase symptoms.
Transition to extensor muscle hypertonia (retrocollis, opisthotonos).
As toxicity worsens during the first week, hypotonia paradoxically shifts to severe hypertonia of the extensor muscles.
4
Identify the advanced acute phase symptoms.
Progression to advanced acute encephalopathy (shrill cry, apnea, seizures, coma).
Massive acute damage to the basal ganglia and brainstem nuclei leads to seizures and coma, indicating severe and likely irreversible acute damage.
5
Identify the chronic, long-term sequelae.
Permanent manifestation of choreoathetoid cerebral palsy and sensorineural hearing loss.
Infants surviving the acute phases develop permanent neurologic deficits (kernicterus) that become apparent during the first year of life.

Anahtar Kavram

Chronological progression of Bilirubin-Induced Neurologic Dysfunction (BIND)
Bu soruyu puanla